Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-005688
Filing Date
2020-05-07
Accepted
2020-05-07 16:06:15
Documents
63
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ardx-20200331x10q.htm 10-Q 1855971
2 EX-31.1 ardx-20200331ex311e8a6bb.htm EX-31.1 22347
3 EX-31.2 ardx-20200331ex3127a4294.htm EX-31.2 22326
4 EX-32.1 ardx-20200331ex321580f90.htm EX-32.1 16898
  Complete submission text file 0001558370-20-005688.txt   6074869

Data Files

Seq Description Document Type Size
5 EX-101.INS ardx-20200331.xml EX-101.INS 1252880
6 EX-101.SCH ardx-20200331.xsd EX-101.SCH 46002
7 EX-101.CAL ardx-20200331_cal.xml EX-101.CAL 52445
8 EX-101.DEF ardx-20200331_def.xml EX-101.DEF 135397
9 EX-101.LAB ardx-20200331_lab.xml EX-101.LAB 331582
10 EX-101.PRE ardx-20200331_pre.xml EX-101.PRE 268470
Mailing Address 34175 ARDENWOOD BLVD. FREMONT CA 94555
Business Address 34175 ARDENWOOD BLVD. FREMONT CA 94555 510-745-7047
ARDELYX, INC. (Filer) CIK: 0001437402 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36485 | Film No.: 20856309
SIC: 2834 Pharmaceutical Preparations